Prevalence of Leukopenia and Associated Outcomes in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-Reference-Cited by-同舟云学术

Prevalence of Leukopenia and Associated Outcomes in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Published:2022-10-01 Issue:10 Volume:158 Page:1212
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Wang Leo L.¹,Noe Megan H.²,Micheletti Robert G.¹

Affiliation:

1. Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia

2. Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts

Abstract

This case series compares the factors, comorbidities, and complications associated with leukopenia between patients with and without leukopenia on hospital admission.

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2795011/jamadermatology_wang_2022_ld_220021_1666117445.3788.pdf

Reference4 articles.

1. Toxic epidermal necrolysis. Granulocytic leukopenia as a prognostic indicator.;Westly;Arch Dermatol,1984

2. Hematological abnormalities and the use of granulocyte-colony-stimulating factor in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.;Ang;Int J Dermatol,2011

3. Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre.;Rajaratnam;Clin Exp Dermatol,2010

4. Stevens-Johnson syndrome/toxic epidermal necrolysis: a multicenter retrospective study of 377 adult patients from the United States.;Micheletti;J Invest Dermatol,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsets;Journal of Clinical Investigation;2024-07-23

2. Treatment of Tislelizumab-Induced Toxic Epidermal Necrolysis and Agranulocytosis: A Case Report and Literature Review;Current Drug Safety;2024-06-20

3. Stevens-Johnson syndrome and toxic epidermal necrolysis: case series and brief literature review;Armenian Journal of Health & Medical Sciences;2023-11-30

4. Outcomes Associated With Neutropenia and Lymphopenia in Epidermal Necrolysis;JAMA Dermatology;2023-03-01